Tunability of pore diameter and particle size of amorphous microporous silica for diffusive controlled release of drug compounds

被引:42
作者
Aerts, Caroline A.
Verraedt, Els
Mellaerts, Randy
Depla, Anouschka
Augustijns, Patrick
Van Humbeeck, Jan
Van den Mooter, Guy
Martens, Johan A.
机构
[1] Katholieke Univ Leuven, Ctr Surface Chem & Catalysis, B-3001 Heverlee, Belgium
[2] Katholieke Univ Leuven, Lab Pharmacotechnol & Biopharm, B-3000 Louvain, Belgium
[3] Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Heverlee, Belgium
关键词
IN-VITRO RELEASE; ORGANIC MODIFICATION; MCM-41; MATRICES; CARRIER; GEL; DELIVERY; XEROGEL; ZEOLITES; IBUPROFEN;
D O I
10.1021/jp0735076
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Amorphous microporous silica (AMS) materials with variation in microporosity were prepared using an acidcatalyzed sol-gel procedure departing from tetraethylorthosilicate. The silicas were fined to specific particle sizes by crushing and sieving. AMS materials were loaded with 10 wt% ibuprofen either by uptake of molten ibuprofen or by adsorption of ibuprofen from a methylene chloride solution. DSC analysis of ibuprofenloaded AMS confirmed the molecular dispersion of ibuprofen on the silica material. In vitro ibuprofen release from AMS carrier was investigated in simulated intestinal fluid and in a dissolution medium simulating the gastrointestinal tract with simulated gastric fluid followed by simulated intestinal fluid. The release of ibuprofen molecules from the AMS silica carrier is governed by diffusion. The diffusivity of ibuprofen in the investigated series of AMS samples was in the range 10(-14)-10(-11) m(2) s(-1). By adapting the porosity and particle size of AMS, the release could be evenly spread over periods from 3 to 100 h. This flexibility of AMS opens perspectives for designing tailor-made controlled release formulations.
引用
收藏
页码:13404 / 13409
页数:6
相关论文
共 40 条
  • [1] Silica xerogel carrier material for controlled release of toremifene citrate
    Ahola, M
    Kortesuo, P
    Kangasniemi, I
    Kiesvaara, J
    Yli-Urpo, A
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 195 (1-2) : 219 - 227
  • [2] In vitro release of heparin from silica xerogels
    Ahola, MS
    Säilynoja, ES
    Raitavuo, MH
    Vaahtio, MM
    Salonen, JI
    Yli-Urpo, AUO
    [J]. BIOMATERIALS, 2001, 22 (15) : 2163 - 2170
  • [3] Bruck S.D., 1983, Controlled Drug Delivery, P1
  • [4] CANHAM LT, 2001, Patent No. 0128529
  • [5] Inclusion of ibuprofen in mesoporous templated silica:: drug loading and release property
    Charnay, C
    Bégu, S
    Tourné-Péteilh, C
    Nicole, L
    Lerner, DA
    Devoisselle, JM
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (03) : 533 - 540
  • [6] Drug release from biodegradable silica fibers
    Czuryszkiewicz, T
    Ahvenlammi, J
    Kortesuo, P
    Ahola, M
    Kleitz, F
    Jokinen, M
    Lindén, M
    Rosenholm, JB
    [J]. JOURNAL OF NON-CRYSTALLINE SOLIDS, 2002, 306 (01) : 1 - 10
  • [7] Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery
    Doadrio, AL
    Sousa, EMB
    Doadrio, JC
    Pariente, JP
    Izquierdo-Barba, I
    Vallet-Regí, M
    [J]. JOURNAL OF CONTROLLED RELEASE, 2004, 97 (01) : 125 - 132
  • [8] The use of zeolites as slow release anthelmintic carriers
    Dyer, A
    Morgan, S
    Wells, P
    Williams, C
    [J]. JOURNAL OF HELMINTHOLOGY, 2000, 74 (02) : 137 - 141
  • [9] Surfactant-modified zeolites as a drug carrier and the release of chloroquin
    Hayakawa, K
    Mouri, Y
    Maeda, T
    Satake, I
    Sato, M
    [J]. COLLOID AND POLYMER SCIENCE, 2000, 278 (06) : 553 - 558
  • [10] Tracking of single molecules as a powerful method to characterize diffusivity of organic species in mesoporous materials -: art. no. 23
    Hellriegel, C
    Kirstein, J
    Bräuchle, C
    [J]. NEW JOURNAL OF PHYSICS, 2005, 7